Anna Smith is a Rheumatology/Immunology physician affiliated with University of Virginia. OpenAlex indexes 19 publications with 799 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Kestra Medical Technology Services, Inc.Program year20251 payment
- Curonix LLCProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
78.8%Leukotriene Receptor Antagonist22.8%Montelukast Sodium100%Part D≥38 patientsCorticosteroid19.1%Breo Ellipta23%Symbicort19%Fluticasone Propionate17%Budesonide-Formoterol Fumarate17%Trelegy Ellipta14%Arnuity Ellipta10%Part D<11 patients+ 7 more classes in this area
Metabolism & gastrointestinal
10.7%Corticosteroid6.1%Prednisone100%Part D≥13 patientsH2 blocker4.6%Famotidine100%Part D<11 patientsDermatology
10.5%Interleukin-4 Receptor alpha Antagonist10.5%Dupixent Pen78%Dupixent Syringe22%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- DIFFERENTIATING EFFECTS OF CO-MORBID PSORIASIS AND ATOPIC DERMATITIS ON CHRONIC RHINOSINUSITIS IMMUNOPATHOLOGY AND CLINICAL PRESENTATION
Annals of Allergy Asthma & Immunology
2025 - THE PHOSPHATASE PLOT TWIST: A CASE OF PTPN2 MUTATION UNMASKING CHRONIC FUNGAL INFECTION AND AUTOIMMUNITY
Annals of Allergy Asthma & Immunology
2025 - Evaluating Social Risk Factors and Their Influence on Lung Function, BMI, and Exacerbation Frequency in Patients With Cystic Fibrosis
American Journal of Respiratory and Critical Care Medicine
2025 - The α-Gal mammalian meat allergy as a cause of isolated gastrointestinal symptoms
Frontiers in Gastroenterology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Mark Deboer, MD
University of Virginia
Jaideep Kapur, MD
University of Virginia
Mark Quigg, MD, MSc
University of Virginia
Ryan Gentzler, MD
University of Virginia
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”